Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 345

1.

Primary Cutaneous Anaplastic Large Cell Lymphoma.

Brown RA, Fernandez-Pol S, Kim J.

J Cutan Pathol. 2017 Mar 25. doi: 10.1111/cup.12937. [Epub ahead of print] Review.

PMID:
28342276
2.

Is CCNU (lomustine) valuable for treatment of cutaneous epitheliotropic lymphoma in dogs? A critically appraised topic.

Laprais A, Olivry T.

BMC Vet Res. 2017 Feb 21;13(1):61. doi: 10.1186/s12917-017-0978-7. Review.

3.

The Search for Potent, Small-Molecule HDACIs in Cancer Treatment: A Decade After Vorinostat.

Zagni C, Floresta G, Monciino G, Rescifina A.

Med Res Rev. 2017 Feb 9. doi: 10.1002/med.21437. [Epub ahead of print] Review.

PMID:
28181261
4.

Janus kinase inhibitors in dermatology: A systematic review.

Shreberk-Hassidim R, Ramot Y, Zlotogorski A.

J Am Acad Dermatol. 2017 Apr;76(4):745-753.e19. doi: 10.1016/j.jaad.2016.12.004. Epub 2017 Feb 4. Review.

PMID:
28169015
5.

Primary Cutaneous Follicular Helper T-cell Lymphoma in a Patient With Neurofibromatosis Type 1: Case Report and Review of the Literature.

Shamsuyarova A, Kamil Z, Delabie J, Al-Faraidy N, Ghazarian D.

Am J Dermatopathol. 2017 Feb;39(2):134-139. doi: 10.1097/DAD.0000000000000697. Review.

PMID:
28134730
6.

T-Cell Non-Hodgkin Lymphomas: Spectrum of Disease and the Role of Imaging in the Management of Common Subtypes.

Park HS, McIntosh L, Braschi-Amirfarzan M, Shinagare AB, Krajewski KM.

Korean J Radiol. 2017 Jan-Feb;18(1):71-83. doi: 10.3348/kjr.2017.18.1.71. Epub 2017 Jan 5. Review.

7.

Challenges and opportunities for checkpoint blockade in T-cell lymphoproliferative disorders.

Phillips T, Devata S, Wilcox RA.

J Immunother Cancer. 2016 Dec 20;4:95. doi: 10.1186/s40425-016-0201-6. eCollection 2016 Dec 20. Review.

8.

T-cell Lymphoma Epidemiology: the Known and Unknown.

Phan A, Veldman R, Lechowicz MJ.

Curr Hematol Malig Rep. 2016 Dec;11(6):492-503. doi: 10.1007/s11899-016-0353-y. Review.

PMID:
27995419
9.

Childhood Non-Hodgkin Lymphoma Treatment (PDQ®): Health Professional Version.

PDQ Pediatric Treatment Editorial Board.

PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US); 2002-.
2016 Nov 30.

10.

The biomarker landscape in mycosis fungoides and Sézary syndrome.

Dulmage B, Geskin L, Guitart J, Akilov OE.

Exp Dermatol. 2016 Nov 28. doi: 10.1111/exd.13261. [Epub ahead of print] Review.

PMID:
27897325
11.

TH9 cells in skin disorders.

Clark RA, Schlapbach C.

Semin Immunopathol. 2017 Jan;39(1):47-54. doi: 10.1007/s00281-016-0607-8. Epub 2016 Nov 28. Review.

PMID:
27896634
12.

Lymphoma of the eyelid.

Svendsen FH, Heegaard S.

Surv Ophthalmol. 2016 Nov 26. pii: S0039-6257(16)30103-5. doi: 10.1016/j.survophthal.2016.11.009. [Epub ahead of print] Review.

PMID:
27894880
13.

Photodynamic therapy as an alternative treatment for relapsed or refractory mycosis fungoides: A systemic review.

Xue J, Liu C, Liu Y.

Photodiagnosis Photodyn Ther. 2017 Mar;17:87-91. doi: 10.1016/j.pdpdt.2016.11.010. Epub 2016 Nov 23. Review.

PMID:
27888162
14.

Mycosis fungoides staged by 18F-flurodeoxyglucose positron emission tomography/computed tomography: Case report and review of literature.

Xu L, Pang H, Zhu J, Chen X, Guan L, Wang J, Chen J, Liu Y.

Medicine (Baltimore). 2016 Nov;95(45):e5044. Review.

15.

Proteomic Approaches to Biomarker Discovery in Cutaneous T-Cell Lymphoma.

Ion A, Popa IM, Papagheorghe LM, Lisievici C, Lupu M, Voiculescu V, Caruntu C, Boda D.

Dis Markers. 2016;2016:9602472. Epub 2016 Oct 16. Review.

16.

The role of 18F-FDG PET and PET/CT in the evaluation of primary cutaneous lymphoma.

Qiu L, Tu G, Li J, Chen Y.

Nucl Med Commun. 2017 Feb;38(2):106-116. doi: 10.1097/MNM.0000000000000614. Review.

PMID:
27792043
17.

Cutaneous T-Cell Lymphoma. A hypothesis on disease pathophysiology involving deficiency in DNA repair.

Thestrup-Pedersen K.

J Eur Acad Dermatol Venereol. 2016 Oct;30(10):1682-1685. doi: 10.1111/jdv.13852. Epub 2016 Aug 8. Review.

PMID:
27501224
18.

T-cell lymphomas, a challenging disease: types, treatments, and future.

Ma H, Abdul-Hay M.

Int J Clin Oncol. 2017 Feb;22(1):18-51. doi: 10.1007/s10147-016-1045-2. Epub 2016 Oct 14. Review.

PMID:
27743148
19.
20.

Malignant inflammation in cutaneous T-cell lymphoma - a hostile takeover.

Krejsgaard T, Lindahl LM, Mongan NP, Wasik MA, Litvinov IV, Iversen L, Langhoff E, Woetmann A, Odum N.

Semin Immunopathol. 2016 Oct 7. doi: 10.1007/s00281-016-0594-9. [Epub ahead of print] Review.

PMID:
27717961

Supplemental Content

Loading ...
Support Center